Knowledge Level of Yazd Dental Students about Medication-Related Osteonecrosis of the Jaw Knowledge Level of Yazd Dental Students about MRONJ
Regeneration, Reconstruction & Restoration (Triple R),
Vol. 9 (2024),
1 January 2024
https://doi.org/10.22037/rrr.v9.45622
Abstract
Background and objectives: This study aimed to assess the knowledge level of Yazd dental students about bisphosphonate-related osteonecrosis of the jaw (MRONJ).
Materials and methods: This cross-sectional study was conducted on 113 fourth- to sixth-year dental students of School of Dentistry, Yazd Shahid Sadoughi University of Medical Sciences. A questionnaire was used to collect information regarding age, gender, academic year, grade point average (GPA), and history of encountering a case of MRONJ. The questionnaire had 13 multiple-choice questions regarding the knowledge level of students about the definition, classification, frequency of use, side effects, risk factors, and indications of bisphosphonates and treatment of MRONJ. Data were analyzed by t-test and Pearson’s correlation test (alpha = 0.05).
Results: A total of 69 (61.1%) female and 44 (38.9%) male dental students participated in this study. The mean knowledge score of students about MRONJ was 14.42 ± 3.84 out of 17. No significant difference was found in the mean knowledge score of male and female students (P = 0.518). Knowledge score of students had significant inverse correlations with their age (r = -0.306, P = 0.001) and academic year (r = -0.184, P = 0.050) and a significant direct correlation with their GPA (r = 0.330, P = 0.000).
Conclusion: The present results revealed good knowledge level of Iranian dental students regarding MRONJ. Knowledge level of students had significant inverse correlations with their age and academic year, and a significant direct correlation with their GPA.
- Bisphosphonate-Associated Osteonecrosis of the Jaw
- studens
- dental knowledge
How to Cite
References
Woo SB, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Annals of internal medicine. 2006;144(10):753-61.
Vasconcelos ACU, Azambuja Berti‐Couto S, Figueiredo MA, Salum FG, Lopes TG, Cherubini K. Laboratory methods and biomarkers in the evaluation of bisphosphonate effects on body tissues: a literature review. Journal of Oral Pathology & Medicine. 2013;42(8):577-86.
Migliorati CA, Siegel MA, Elting LS. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. The lancet oncology. 2006;7(6):508-14.
Dannemann C, Grätz K, Riener M, Zwahlen R. Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder. Bone. 2007;40(4):828-34.
Yazdani J, Mortazavi A, Abbasi E. Knowledge of Tabriz Dentists about Bisphosphonate-Related Osteonecrosis of the Jaw in 2015. Med J Tabriz Uni Med Sciences Health Services. 2019;41(3):101-5.
Heidari M, motevali S, Maboodi A, Sobouti F. Is using Bisphosphonate a Contraindication for Dental Treatments? Journal of Mazandaran University of Medical Sciences. 2017;27(154):232-44.
Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer. 2005;104(1):83-93.
Ficarra G, Beninati F, Rubino I, Vannucchi A, Longo G, Tonelli P, Pini Prato G. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. Journal of clinical periodontology. 2005;32(11):1123-8.
Madrid C, Sanz M. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Clinical oral implants research. 2009;20 Suppl 4:87-95.
Assael LA. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. Journal of Oral and Maxillofacial Surgery. 2009;67(5):35-43.
Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez G, Silver P, Chandra M. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. Journal of Oral and Maxillofacial Surgery. 2010;68(2):243-53.
Beninati F, Pruneti R, Ficarra G. Bisphosphonate-related osteonecrosis of the jaws (Bronj). Medicina oral, patologia oral y cirugia bucal. 2013;18(5):e752-8.
Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update. Journal of Oral and Maxillofacial Surgery. 2009;67(5):2-12.
Markiewicz MR, Margarone JE, Campbell JH, Aguirre A. Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge. The Journal of the American Dental Association. 2005;136(12):1669-74.
Rosella D, Papi P, Pompa G, Capogreco M, De Angelis F, Di Carlo S. Dental students' knowledge of medication-related osteonecrosis of the jaw. European journal of dentistry. 2017;11(4):461-8.
López‐Jornet P, Camacho‐Alonso F, Molina‐Miñano F, Gomez‐Garcia F. Bisphosphonate‐associated osteonecrosis of the jaw. Knowledge and attitudes of dentists and dental students: a preliminary study. Journal of evaluation in clinical practice. 2010;16(5):878-82.
Escobedo M, García-Consuegra L, Junquera S, Olay S, Ascani G, Junquera L. Medication-related osteonecrosis of the jaw: A survey of knowledge, attitudes, and practices among dentists in the principality of Asturias (Spain). Journal of stomatology, oral and maxillofacial surgery. 2018;119(5):395-400.
de Lima PB, Brasil VL, de Castro JF, de Moraes Ramos-Perez FM, Alves FA, dos Anjos Pontual ML, da Cruz Perez DE. Knowledge and attitudes of Brazilian dental students and dentists regarding bisphosphonate-related osteonecrosis of the jaw. Supportive care in cancer. 2015;23(12):3421-6.
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F.American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 2014;72(10):1938-56.
Zargaran M, Baghaei F. A review of bisphosphonates and bisphosphonate-related osteonecrosis of the jaw. Journal of dentistry (Shiraz university of medical sciences). 2012;12(4):376-87.
Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 2003;61(9):1115-7.
Escobedo MF, García-Consuegra L, Gay S, Álvarez L, Olay S, Ascani G, Junquera L. Influence of the teaching program on the learning in knowledge and practice of osteonecrosis of the jaws produced by antireasorptives in dental students of the Principality of Asturias (Spain). Journal of clinical and experimental dentistry. 2017;9(12):e1402-7.
Monwell B, Blix O, Gerdner A, Bülow P. Drug List as a Cognitive Support to Provide Detailed Information on a Patient's Drug Use: A Comparison of Two Methods Within the Assessment of Drug Misuse and Dependence. Substance use & misuse. 2016;51(11):1470-6.
Fonseca RJ, Marciani RD, Turvey TA. Oral and Maxillofacial Surgery. 2th ed. St.Louis. Saunders Elsevier ; 2009. (pp 395-396, 557-564).
Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2006;102(4):433-41.
Marx RE, Cillo JE, Jr., Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 2007;65(12):2397-410.
Gavaldá C, Bagán JV. Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws. A review of the literature. Medicina oral, patologia oral y cirugia bucal. 2016;21(3):e260-70.
Rogers MJ, Watts DJ, Russell RG. Overview of bisphosphonates. Cancer. 1997;80(8 Suppl):1652-60.
Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. The New England journal of medicine. 2005;353(1):99-102.
Samiee rad S, labafchi a. Management of Medication-Related Osteonecrosis of the Jaw Using Platelet-Rich Fibrin: A Case Report and Literature Review. Journal of Mashhad Dental School. 2020;44(2):191-200.
George EL, Lin YL, Saunders MM. Bisphosphonate-related osteonecrosis of the jaw: a mechanobiology perspective. Bone Reports. 2018;8:104-9.
- Abstract Viewed: 141 times
- PDF Downloaded: 88 times